AI Drug Detection Platform Isomorphic Labs Blooms $ 600 Million

Isomorphic Labs, AI Drug Detection Platform, which was Spin out of the depths of Google For the first time in 2021 he raised foreign capital. The $ 600 million stage was headed by prosperous capital by participating in GV and Google’s parents’ alphabet. It is said to beA number

Funding will accelerate the further development of Isomorphic’s AI drug design engine and will support the company’s goal to bring its found drugs to clinical trials.

Isomorphic Labs was founded by DeepMind Co-Founder Demis Hassabis, Deepmind’s Software for Detection AI, including Alphafold, AI, which predicts three-dimensional proteins.

Last year, Isomorphic Labs provided strategic partnerships with Eli Lily and Novart, potential Creating up to $ 3 billion In the most important payments to access his AI model.

Told Hasabis New York Times: It was no need for capitalphic Labs, additional funding would help divide the best research scientists in the section.

AlphaFold’s, hassabis and Deepmind researcher John Jum bin were three scientists who received a Nobel Prize in Chemistry In 2024.